{"id":"arb-001467","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fatigue"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the replication of the virus, which can lead to the reduction of viral load and the alleviation of symptoms associated with hepatitis B infection.","oneSentence":"ARB-001467 is an investigational drug that targets the hepatitis B virus.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:29:06.711Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis B"}]},"trialDetails":[{"nctId":"NCT02631096","phase":"PHASE2","title":"Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy","status":"COMPLETED","sponsor":"Arbutus Biopharma Corporation","startDate":"2015-12","conditions":"Hepatitis B, Chronic","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ARB-001467","genericName":"ARB-001467","companyName":"Arbutus Biopharma Corporation","companyId":"arbutus-biopharma-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ARB-001467 is an investigational drug that targets the hepatitis B virus. Used for Chronic hepatitis B.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}